Sanj K Patel insider trades
Open-market stock purchases and sales by Sanj K Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc, from SEC Form 4 filings since Dec 20, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold (not open market) | $1.2M |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold (not open market) | $1.2M |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Sep 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Jun 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $2.6M |
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Apr 30, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $116K |
| Apr 30, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Apr 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $1.2M |
| Apr 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Bought (not open market) | — |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $3.8M |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $5.9M |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $12.7M |
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Sold | $2.8M |
Companies traded
- KNSA Kiniksa Pharmaceuticals International, plc: 1 buy, 39 sales, last Sep 1, 2026
- SYRS Syros Pharmaceuticals, Inc: other filings, last Jun 8, 2017
- BCRX Biocryst Pharmaceuticals Inc: other filings, last May 24, 2017
- GEVA Synageva Biopharma Corp: 48 sales, last Jun 22, 2015
- ICPT Intercept Pharmaceuticals Inc: other filings, last Jul 17, 2014